Distinguishing Curable from Progressive Dementias for Defining Cancer Care Options

CH Schein - Cancers, 2023 - mdpi.com
Simple Summary The median age of diagnosis of dementia, as well as for many cancers, is
above 60 years. Dementia should not exclude even frail, elderly patients from cancer …

In silico discovery of novel calcineurin inhibitors using ligand-based 3-D pharmacophore modelling and molecular dynamics simulation

N R. M, A Joy - Journal of Biomolecular Structure and Dynamics, 2024 - Taylor & Francis
Calcineurin is a serine-threonine protein phosphatase that is activated with the binding of
calmodulin in the presence of increased calcium concentration and has a major role in …

Computational Evaluation of Curcumenol as a Potential Inhibitor against Calcineurin Protein

NRM Nivya, A Joy - Current Trends in Biotechnology and Pharmacy, 2024 - abap.co.in
Calcineurin protein is a multifunctional serine-threonine protein phosphatase vital to several
cellular functions, such as immune response control, signal transduction, and cardiac …

Формування ультраструктурних адаптивних реакцій у тканинах організму при експериментальному паркінсонізмі

ЮВ Путій, ОЛ Фучко, НМ Ващенко - 2023 - dspace.uzhnu.edu.ua
Вивчали зміни ультраструктури тканин довгастого мозку, стріатума, легень та серця
при експе риментальному паркінсонізмі, викликаному дією ротенону, який вводили …

[ZITATION][C] Distinguishing Curable from Progressive Dementias for Defining Cancer Care Options. Cancers 2023, 15, 1055

CH Schein - 2023 - europepmc.org
The likelihood of a diagnosis of dementia increases with a person's age, as is also the case
for many cancers, including melanoma and multiple myeloma, where the median age of …